Company Data

Atreca Inc.

Ticker
BCEL
Current Price
$0.09
Market Cap
$3.6M
Price Target
Refer to Report
Volume
736.5K
52wk Range
$0.052 - $1.0019
Advanced Market Data

Overview

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company’s product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy